Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study

This trial was conducted to assess the activity and tolerability of the gemcitabine, epirubicin, taxol triplet combination in patients with operable breast cancer. After core biopsy, 43 women with stage II-IIIA breast cancer were treated with gemcitabine 1000 mg m(-2) over 30 min on days 1 and 4, ep...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2005-08, Vol.93 (4), p.406-411
Hauptverfasser:	CONTE, P. F, DONATI, S, NACCARATO, A. G, ESPOSTI, R. Degli, BONARDI, S, BOTTINI, A, SARACCHINI, S, TUMOLO, S, GULLO, G, SANTORO, A, CRINO, L, GENNARI, A, GUARNERI, V, ORLANDINI, C, RONDINI, M, RONCELLA, M, MARINI, L, COLLECCHI, P, VIACAVA, P
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Biomarkers, Tumor Breast Neoplasms - drug therapy Breast Neoplasms - surgery Clinical Study Combined Modality Therapy Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Epirubicin - administration & dosage Female Gynecology. Andrology. Obstetrics Humans Infusions, Intravenous Injections, Intravenous Mammary gland diseases Medical sciences Middle Aged Survival Analysis Taxoids - administration & dosage Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!